Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series
Manuel Alfredo Podestà(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Piero Ruggenenti(Mario Negri Institute for Pharmacological Research)
Cited by 33
Related Papers
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial
|The Lancet|2005|644
Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort Study
|American Journal of Nephrology|2011|71